These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1077 related items for PubMed ID: 25504382

  • 21. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 22. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T.
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [Abstract] [Full Text] [Related]

  • 23. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW.
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [Abstract] [Full Text] [Related]

  • 24. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, Frediani B, Rossini M, BONTURNO study group.
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [Abstract] [Full Text] [Related]

  • 25. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH.
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [Abstract] [Full Text] [Related]

  • 26. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 27. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 28. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 29. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB.
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [Abstract] [Full Text] [Related]

  • 30. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of bone turnover by milk intake in postmenopausal women.
    Bonjour JP, Brandolini-Bunlon M, Boirie Y, Morel-Laporte F, Braesco V, Bertière MC, Souberbielle JC.
    Br J Nutr; 2008 Oct 15; 100(4):866-74. PubMed ID: 18298870
    [Abstract] [Full Text] [Related]

  • 32. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
    Grey A, Bolland MJ, Horne A, Wattie D, House M, Gamble G, Reid IR.
    Bone; 2012 Jun 15; 50(6):1389-93. PubMed ID: 22465268
    [Abstract] [Full Text] [Related]

  • 33. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ, Shen L, Yang YP, Lu FR, Zhu R, Shuai B, Li CG, Wu MX.
    Chin Med J (Engl); 2013 Jul 15; 126(13):2480-4. PubMed ID: 23823821
    [Abstract] [Full Text] [Related]

  • 34. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study.
    Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E, Valero C, González-Macías J.
    Clin Chim Acta; 2009 Nov 15; 409(1-2):70-4. PubMed ID: 19737549
    [Abstract] [Full Text] [Related]

  • 35. [Early, noninvasive diagnostic of osteoporosis in men].
    Lepiarz-Rusek W, Kokocińska D.
    Przegl Lek; 2005 Nov 15; 62(7):641-9. PubMed ID: 16463693
    [Abstract] [Full Text] [Related]

  • 36. Changes of bone turnover markers after elderly hip fracture surgery.
    Li XP, Li XY, Yang MH, Zhu SW, Wu XB, Zhang P.
    J Bone Miner Metab; 2021 Mar 15; 39(2):237-244. PubMed ID: 32876727
    [Abstract] [Full Text] [Related]

  • 37. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H, JPOS Study Group.
    Osteoporos Int; 2006 Mar 15; 17(7):1086-95. PubMed ID: 16758145
    [Abstract] [Full Text] [Related]

  • 38. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.
    J Bone Miner Res; 2000 Aug 15; 15(8):1526-36. PubMed ID: 10934651
    [Abstract] [Full Text] [Related]

  • 39. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN, Novakovic TR, Markovic-Jovanovic SR, Smilic LLJ, Mitic JS, Radunovic ML.
    J Clin Densitom; 2018 Aug 15; 21(3):322-328. PubMed ID: 29103946
    [Abstract] [Full Text] [Related]

  • 40. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
    Garnero P, Mulleman D, Munoz F, Sornay-Rendu E, Delmas PD.
    J Bone Miner Res; 2003 Oct 15; 18(10):1789-94. PubMed ID: 14584889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.